Hitzman Cory J, Wiedmann Timothy S, Dai Haiqing, Elmquist William F
Department of Pharmaceutics, University of Minnesota, 308 Harvard Street SE, Minneapolis, MN 55455, USA.
J Pharm Sci. 2005 Jul;94(7):1456-66. doi: 10.1002/jps.20349.
The purpose of this study was to examine the feasibility of the microdialysis sampling technique as a method to precisely and conveniently measure drug release from microcarrier systems such as liposomes and microspheres. Release of 5-fluorouracil (5-FU) from liposomes and microspheres was evaluated in vitro using microdialysis. Retrodialysis calibration using 5-chlorouracil (5-CU) was performed in conjunction with on-line HPLC analysis. At a microdialysis perfusate flow rate of 0.5 muL/min, concurrent 5-FU gain and 5-CU loss ranged from 72% to 75%, while concurrent 5-FU loss and 5-CU ranged from 69% to 71%. After calibration, simultaneous 5-FU release profiles were obtained by continuous microdialysis and discrete equilibrium dialysis sampling using a side-by-side diffusion apparatus. Release rates were characterized by a first-order release model. The release rate constants for a representative liposomal formulation were 0.30 and 1.85/h by microdialysis in the acceptor and donor compartments, respectively, and 0.39/h by equilibrium dialysis in the acceptor compartment. The calculated release rate constant determined by equilibrium dialysis in the donor compartment (1.98/h) agrees with that determined by microdialysis (1.85/h) when the resistance of the equilibrium dialysis membrane with associated first-order rate constant of transfer of 0.42/h is taken into account. Release profiles of 5-FU from a number of different liposome and microsphere formulations were determined. The results indicate that a convenient and reproducible characterization of drug release from various liposome and microsphere formulations is readily obtainable by microdialysis.
本研究的目的是检验微透析采样技术作为一种精确且便捷地测量药物从脂质体和微球等微载体系统中释放的方法的可行性。使用微透析在体外评估了5-氟尿嘧啶(5-FU)从脂质体和微球中的释放情况。结合在线高效液相色谱分析,使用5-氯尿嘧啶(5-CU)进行了反透析校准。在微透析灌注液流速为0.5 μL/min时,5-FU的同时增加和5-CU的同时减少范围为72%至75%,而5-FU的同时减少和5-CU的范围为69%至71%。校准后,通过连续微透析和使用并排扩散装置的离散平衡透析采样获得了5-FU的同步释放曲线。释放速率通过一级释放模型进行表征。对于一种代表性的脂质体制剂,在接受室和供体室中通过微透析测得的释放速率常数分别为0.30和1.85/h,在接受室中通过平衡透析测得的释放速率常数为0.39/h。当考虑到平衡透析膜的阻力以及相关的一级转移速率常数为0.42/h时,在供体室中通过平衡透析计算得到的释放速率常数(1.98/h)与通过微透析确定的释放速率常数(1.85/h)一致。测定了多种不同脂质体和微球制剂中5-FU的释放曲线。结果表明,通过微透析可以方便且可重复地表征各种脂质体和微球制剂中的药物释放情况。